Pharma & Biotech

Myriad Genetics has announced compelling new clinical evidence supporting its GeneSight Psychotropic test. A comprehensive meta-analysis released yesterday, which included...

QuidelOrtho shares closed Wednesday's session at $27.61, marking a decline of 2.27%. This downward movement occurred even as RBC Capital...

At the recent Wells Fargo Healthcare Conference, Vertex Pharmaceuticals CEO Reshma Kewalramani underscored the profound strategic importance of the company's...

Krystal Biotech finds itself at a critical juncture this week as market participants weigh recent operational successes against emerging challenges....

Danaher Corporation presents investors with a compelling puzzle. The global life sciences and diagnostics giant continues to deliver robust quarterly...

Assembly Biosciences continues to face significant headwinds in the equity markets, with its stock price locked in a persistent decline....

Pharmaceutical titan Eli Lilly & Co. finds itself at the center of a Wall Street debate, presenting investors with a...

Compass Therapeutics has captured market attention through a combination of promising clinical data and strategic financial maneuvers. While analyst sentiment...

The recent performance of 10X Genomics (TXG) presents investors with a fascinating puzzle: how can a company deliver impressive quarterly...

Corbus Pharmaceuticals shares edged higher in after-hours trading, reaching $9.93 after closing at $9.74—a gain of nearly 2 percent. Investor...